[关键词]
[摘要]
眼部疾病是全球的重要健康问题。代谢组学是对一个系统中的代谢物进行识别和定量的新兴研究技术,可用于阐明疾病机制及识别新的生物标志物,为深入探究眼部疾病的发生和发展提供了新的策略。本文简介了代谢组学的基本技术,汇总分析了代谢组学在糖尿病视网膜病变、年龄相关性黄斑变性、青光眼和干眼四种眼部疾病中的最新研究进展,总结了潜在的生物标志物和代谢途径,并对代谢组学在未来眼部疾病管理和治疗中的应用前景进行了展望。
[Key word]
[Abstract]
Ocular diseases pose a significant challenge to global health. The field of metabolomics, which involves the systematic identification and quantification of metabolites within a biological system, has emerged as a promising research approach for unraveling disease mechanisms and discovering novel biomarkers. Through its application, metabolomics has yielded valuable knowledge pertaining to the initiation and advancement of various ocular diseases. This review presents an overview of metabolomics and examines recent research progess in four ocular diseases, specifically diabetic retinopathy, age-related macular degeneration, glaucoma, and dry eye, summarizing potential biomarkers and metabolic pathways associated with these diseases. Additionally, this review offers insights into the future prospects of utilizing metabolomics for the management and treatment of ocular diseases.
[中图分类号]
[基金项目]
江苏省自然科学基金(No.BK20201114); 南京鼓楼医院临床专项(No.2022-LCYJ-MS-36)